About Index Trending news
Lists
Pricing
TrovaGene

TrovaGene

TrovaGene

Trovagene’s Precision Cancer Monitoring technology allows physicians to monitor cancer treatment status with a simple urine or blood test. #liquidbiopsy

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding
Post-IPO equity
$7,100,000
Debt financing
$15,000,000
Employees

Team size

10+
Locations
HQ
$7,100,000 Post-IPO equity
Drug Delivery Business

Trovagene raises $7m for precision cancer therapies